Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 4ya34 | IM / RA |
No adverse reaction. Patient had received 1st Boostrix 02/11/2025. Patient had received burns on legs from hydrochloric acid and requested a booster. Patient felt the booster was helping the healing of his legs. Out of caution I am reporting the event. General dosing considerations in Facts and Comparisons states that Tdap can be administered regardless of the interval between the last Tdap vaccine but I am reporting due to an abundance of caution.
Bupropion xl 150 ,ticagrelor 90mg , Atorvastatin 40mg ,Meclizine 12.5, Fenofibrate 160mg, Carvedilol 12.5, Vitamin D2 1.25mg, ALBUTEROL MDI, Nifedipine ER 60mg, Furosemide 40mg
NKA
No adverse reaction and no follow-up